Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma

Y M Geurts, S I M Neppelenbroek, B M P Aleman, C P M Janus, A D G Krol, D J van Spronsen, W J Plattel, J M Roesink, K M S Verschueren, J M Zijlstra, H R Koene, M R Nijziel, E C Schimmel, E de Jongh, F Ong, L C J Te Boome, R S van Rijn, L H Böhmer, B D P Ta, H P J VisserE F M Posthuma, Y M Bilgin, K Muller, D van Kampen, C So-Osman, J S P Vermaat, R J de Weijer, M J Kersten, F E van Leeuwen, M Schaapveld*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science